Soluble LRIG2 is a potential biomarker for type 2 diabetes mellitus

BACKGROUND: Early diagnosis and treatment of type 2 diabetes can delay the onset of microvascular and macrovascular complications. Therefore, the identification of a novel biomarker for diagnosing diabetes is necessary. In the present study, the role of serum soluble leucine-rich repeats and immunog...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Ji Min, Joung, Kyong Hye, Lee, Jun Choul, Choung, Sorim, Kang, Seon Mee, Kim, Hyun Jin, Ku, Bon Jeong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8640903/
https://www.ncbi.nlm.nih.gov/pubmed/34926656
http://dx.doi.org/10.21037/atm-21-3272

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8640903/
https://www.ncbi.nlm.nih.gov/pubmed/34926656
http://dx.doi.org/10.21037/atm-21-3272

Ejemplares similares